PubRank

Dina Kremsdorf

Author PubWeight™ 28.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 2009 2.58
2 Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 2007 1.23
3 Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J Infect Dis 2006 1.21
4 Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene 2002 1.20
5 Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol 2003 1.12
6 Plasticity of hepatic cell differentiation: bipotential adult mouse liver clonal cell lines competent to differentiate in vitro and in vivo. Stem Cells 2006 1.11
7 IL-15 transpresentation promotes both human T-cell reconstitution and T-cell-dependent antibody responses in vivo. Proc Natl Acad Sci U S A 2011 1.10
8 A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Hepatology 2003 1.06
9 The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol 2003 1.05
10 Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes. Proc Natl Acad Sci U S A 2004 1.04
11 Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice. PLoS One 2011 0.99
12 Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol 2009 0.98
13 Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A 2002 0.96
14 Rescue of fertility in homozygous mice for the urokinase plasminogen activator transgene by the transplantation of mouse hepatocytes. Cell Transplant 2008 0.95
15 Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients. J Virol 2007 0.87
16 Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease. J Infect Dis 2008 0.86
17 Detection and genotyping of human papillomavirus by real-time PCR assay. J Clin Virol 2012 0.85
18 Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. J Hepatol 2013 0.84
19 Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogens. Dis Model Mech 2008 0.83
20 Morphogenetic competence of HNF4 alpha-deficient mouse hepatic cells. J Hepatol 2008 0.83
21 Human MxA protein participates to the interferon-related inhibition of hepatitis B virus replication in female transgenic mice. J Hepatol 2005 0.82
22 Regulation of interleukin-6 in head and neck squamous cell carcinoma is related to papillomavirus infection. J Proteome Res 2014 0.81
23 Role of the hepatitis B virus proteins in pro- and anti-apoptotic processes. Front Biosci (Landmark Ed) 2010 0.80
24 Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways. J Gen Virol 2002 0.80
25 Transplanted hepatocytes over-expressing FoxM1B efficiently repopulate chronically injured mouse liver independent of donor age. Mol Ther 2007 0.78
26 Production of hepatitis B defective particles is dependent on liver status. Virology 2012 0.77
27 Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. World J Gastroenterol 2008 0.77
28 Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoring. J Virol Methods 2008 0.76
29 Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant. Antivir Ther 2010 0.76